XML 14 R4.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Operating expenses:        
Research and development $ 19,470 $ 17,379 $ 54,048 $ 39,207
General and administrative 4,883 4,159 14,399 11,164
Total operating expenses 24,353 21,538 68,447 50,371
Loss from operations (24,353) (21,538) (68,447) (50,371)
Other income, net 23 135 94 875
Net loss (24,330) (21,403) (68,353) (49,496)
Net unrealized gain (loss) on short-term marketable securities (8) (74) (14) 22
Comprehensive loss $ (24,338) $ (21,477) $ (68,367) $ (49,474)
Net loss per common share, basic and diluted $ (0.70) $ (0.63) $ (1.96) $ (1.63)
Weighted-average number of shares used in computing net loss per common share, basic and diluted 34,862,116 34,002,769 34,807,439 30,381,671